Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Latest Information Update: 16 Feb 2023
At a glance
- Drugs UTAA-06 (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- Sponsors PersonGen Biotherapeutics
- 16 Feb 2023 New trial record